Search
Research
Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024Respiratory Syncytial Virus (RSV) causes a significant burden of illness for children under 2 years of age. Nirsevimab, a long-acting monoclonal antibody, was registered for RSV prevention in Australia in 2023. In April 2024, Western Australia (WA) launched the country's first state-wide nirsevimab program for all infants and high-risk children entering their second RSV season.
Research
Research priorities for preterm lung health research across the lifespan: a community priority setting partnershipIt is essential to embed patient and public perspectives into every stage of the research journey, including setting the future research agenda. The substantial gaps in our understanding of prematurity-associated lung disease presented a timely opportunity to determine the community's research priorities.
Research
Validity of using a semi-automated screening tool in a systematic review assessing non-specific effects of respiratory vaccinesThe abstract screening process of systematic reviews can take thousands of hours by two researchers. We aim to determine the reliability and validity of Research Screener, a semi-automated abstract screening tool within a systematic review on non-specific and broader effects of respiratory vaccines on acute lower respiratory infection hospitalisations and antimicrobial prescribing patterns in young children.
Read about Biostatistician Grant Smith at the Children's Diabetes Centre.
We are trying to understand what underlies mental health problems in young people with diabetes, with a school-related focus, and how we can best treat them.
Our research focuses on what are the best ways for patients with type 1 diabetes to exercise safely.
Much of our research focuses on the safety and the use of emerging technologies for insulin pumps and other diabetes treatment technology.
We recognise that we can learn a lot from our families. This area of research looks at the reasons why families living with diabetes choose whether or not to participate in research.
News & Events
Seed Funding GrantsThe Rio Tinto Children's Diabetes Centre; a Breakthrough T1D Centre of Excellence is excited the announce the latest round of seed funding recipients.
